This study is to develop an export 1050MPa-class lightweight ductile iron castings Austempered control arm through the research process to obtain the following results. First, the structure of the optimal design Layout design and development of the component, and then achieve them through the Control Arm rigidity and optimal structure design and robust design of the focus areas of the expected stress Control Arm. Second, to develop a Control Arm reflects the high rigidity and high performance lightweight structures. Control Arm them developed to meet the design and rigidity as required by the consumer through the hollow, and to develop a process for the Core. Third, through optimum alloy composition and heat treatment methods will be derived to derive the amount of iron alloy (Cu, Ni, Mo) and Austempered heat treated and tempered condition. Fourth, through the development of optimum molding technology development component to develop the optimum ADI for the low-stiffness, high-rigidity component development, it attempts to develop a high-strength casting forming technology.

The purpose of this study was to introduce the toxicological study review to evaluate the safety of PDMS on the 69th JECFA meeting. Polydimethylsiloxane is a polymer and its ADI was established at 23rd JECFA meeting in 1979. The ADI was maintained although the specification was expanded at its 26th, 29 th, 37 th meetings. Recently, it was reported that PDMS with low molecular weight and viscosity has high absorption rate and different toxicity, so it was submitted at 69th meeting. Toxicological studies of PDMS were submitted from the sponsor and additional information is collected from a document searching. The toxicological studies were reviewed in accordance with the 'Guidelines for the preparation of toxicological working papers for the Joint FAO/WHO Expert Committee on Food Additives'. In the available acute, sub-chronic and chronic toxicity studies on PDMS, dose-related increases in incidence and severity of ocular lesions(corneal crystal, inflammation of the corneal epithelium etc.) were consistently observed after oral dosing. It seems to be a local irritant effect, but the mechanism by which the ocular lesions arose is unclear, although the lack of absorption of PDMS indicates that it is unlikely to be a direct systemic effect. Consequently, the relevance of the ocular lesions for food use of PDMS could not be determined. The ADI of PDMS was re-established from 0-1.5 mg/kg bw/day to 0-0.8 mg/kg bw/day by applying additional safety factor 2 based on its ocular toxicity. The result of 0-0.8 mg/kg bw/day is a temporary ADI until further data are provided to 2010.